![]() They claim Endo's opioid medication Opana ER was marketed aggressively in the state without proper safeguards, contributing to high rates of addiction and death. Stranch's legal team filed a series of complaints with the court about Endo's conduct in the case, which led to the judge's order.Ī controversial opioid, a devastating epidemicĪt issue is a lawsuit filed in 2017 by county prosecutors and other local government officials in eastern Tennessee. " lawyers crossed the line and worked with the company to subvert the court's orders and then made false statements to the court about it," he said. In a statement emailed to NPR the company said it will appeal the judgement.īut Gerard Stranch, one of the attorneys suing the drugmaker on behalf of local governments in Tennessee, said Endo and its lawyers "conspired to hide the truth" over a period of years as the fact-finding phase of the trial proceeded. Moody in a judgment issued on April 6.Įndo denies wrongdoing. "It appears to the court that Endo and its attorneys, after delaying trial, have resorted to trying to improperly corrupt the record," wrote Chancellor E.G. ![]() The judge presiding over the civil trial also concluded the drugmaker and its attorneys made at least a dozen false statements during the pretrial fact-finding process. The Attorney General believes the complaint should be made available to the public in its entirety and efforts to keep it confidential will only prolong and diminish Endo’s accountability for its conduct.A state judge in Tennessee ruled the drug company Endo Pharmaceuticals is liable for harm caused by their opioid drug, Opana ER.Ī state court in Tennessee has punished Endo Pharmaceuticals for improperly withholding a vast trove of documents relating to the sale and marketing of its opioid medication Opana ER. ![]() The order sealed by the judge allows the seal to expire in 10 days unless Endo acts to extend it. ![]() The Attorney General requested the complaint be filed under a temporary seal because Endo claims the information produced during the State’s investigation is confidential. Endo provided significant funding to other third-party groups and subsequently relied on material generated by those groups without disclosing the financial relationship. The State also has reason to believe Endo used the recommendations and educational materials of third-party groups like the American Pain Foundation without disclosing that Endo was by far the biggest donor to the Foundation and provided more than half of its total funding. The Complaint alleges that Endo also knew the dangers of its opioid products, including increased risks of respiratory depression and death in elderly patients, and failed to clearly disclose those risks while it specifically targeted patients in that age group. It did this despite evidence to the contrary, including the FDA’s explicit rejection of Endo’s claim that Opana ER was resistant to abuse as well as overwhelming evidence that Opana ER was being abused throughout Tennessee. The allegations in the State’s 180-page complaint detail how Endo deceptively marketed its opioid products as being less addictive and more effective than others on the market. “Endo has repeatedly refused to take responsibility for its unconscionable conduct, which is why we are taking this action.” “Our Office has conducted an extensive investigation into Endo’s unlawful marketing practices which included targeting vulnerable populations like the elderly,” said Tennessee Attorney General Herbert H. The State’s lawsuit, filed in Knoxville, alleges Endo violated the Tennessee Consumer Protection Act and contributed to a devastating public health crisis in Tennessee. (Endo) for making unlawful and false claims about the safety and benefits of its opioid products. Slatery III today sued Endo Pharmaceuticals and Endo Health Solutions Inc. Here are details from the news release by Attorney General Herbert Slatery’s office:Īttorney General Herbert H. The AG’s office says Endo violated the Tennessee Consumer Protection Act and contributed to a devastating health crisis in Tennessee. The Tennessee Attorney General is suing Endo for making unlawful and false claims about the safety and benefits of its opioid products. TN Attorney General sues opioid maker Endo Pharmaceuticals (photo courtesy Times News)Įndo Pharmaceuticals, the same company which was at the center of a $193 million settlement with one of James Hoyer’s whistleblower clients, is now facing another major legal battle.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |